News | May 06, 2007

Stereotaxis Introduces First Fully Integrated, Networked Single-Screen Solution for Interventional EP Lab

May 7, 2007 Stereotaxis Inc. announced today that it has developed an innovative new single-screen user interface that provides an unprecedented level of interventional lab integration. The product, Odyssey, is a proprietary Stereotaxis design that consolidates multiple information sources and screens within an electrophysiology interventional lab into a single visual display.

Typically, interventional physicians are faced with the challenge of interacting simultaneously with multiple systems and screens, and diverse sources of diagnostic and imaging information during a procedure. Odyssey consolidates all these sources of information into a single, manageable format, dramatically simplifying the interventional lab and potentially bringing greater simplicity and efficiency to electrophysiology procedures.

Odyssey installations will be connected through Global Crossing's worldwide IP Virtual Private Network (VPN) Service to a remote Clinical Services Center, located at Stereotaxis Headquarters in St. Louis, MO. The Clinical Services Center will enable Stereotaxis to remotely support clinical procedures, providing customers with on demand technical support and training at the touch of a button from their lab.

For the first time, diagnostic and imaging information will be available remotely, enabling Stereotaxis to deliver unprecedented levels of customer support. In combination, the Odyssey consolidated visual display, private network, and remote Clinical Services Center are expected to uniquely position Stereotaxis to provide a comprehensively integrated solution to hospitals, potentially improving the efficacy and efficiency of their interventional labs. It is expected that the Odyssey Network will provide a foundation for a family of future networked products and services.

Odyssey has been installed at a number of Stereotaxis clinical
sites, including San Raffaele University Hospital in Milan, Italy, and the University of Ottawa Heart Institute in Ottawa, Canada.

For more information visit

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init